Skip to main content

Peer Review reports

From: Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19

Original Submission
20 Nov 2021 Submitted Original manuscript
12 Dec 2021 Author responded Author comments - Deborah Enting
Resubmission - Version 2
12 Dec 2021 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
5 Feb 2022 Reviewed Reviewer Report
22 Feb 2022 Reviewed Reviewer Report
24 Mar 2022 Author responded Author comments - Deborah Enting
Resubmission - Version 4
24 Mar 2022 Submitted Manuscript version 4
28 Mar 2022 Author responded Author comments - Deborah Enting
Resubmission - Version 5
28 Mar 2022 Submitted Manuscript version 5
4 Apr 2022 Author responded Author comments - Deborah Enting
Resubmission - Version 6
4 Apr 2022 Submitted Manuscript version 6
9 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
12 Apr 2022 Editorially accepted
29 Apr 2022 Article published 10.1186/s12894-022-01023-6

You can find further information about peer review here.

Back to article page